Login Register Cart 0
Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Cutaneous Manifestations of Novel Coronavirus Disease (COVID-19): A Case with Staphylococcal Scalded Skin Syndrome (SSSS)

Author(s): Ali Hosseininasab, Reza Sinaei, Sarehossadat Ebrahimi, Saeedeh Parvaresh and Maedeh Jafari*

Volume 18, Issue 3, 2022

Published on: 27 May, 2022

Page: [228 - 230] Pages: 3

DOI: 10.2174/1573398X18666220411121046

Price: $65

Abstract

Background: The coronavirus disease 2019 (COVID‐19) was first reported in December 2019 in Wuhan, China. Skin manifestations of COVID-19 have been reported sporadically. Staphylococcus aureus occurs after viral infection due to unregulated IFN-α. We designed this reported case to pay more attention to the rare skin manifestations following COVID-19.

Case Report: The patient was a 12-month-old girl who presented with fever and skin rashes. Two days before admission, erythematous rashes spread around the mouth, nose, eyes, and trunk. Erythematous lesions begin to peel the next day. RT-PCR of the nasopharynx was positive for COVID- 19. Treatment with vancomycin and clindamycin was started. The patient was discharged with complete recovery of skin lesions.

Conclusion: One of the early manifestations of COVID-19 in children can be fever and rash. Clinical suspicion led to more attention to complications of bacterial superinfection such as staphylococcal scalded skin syndrome.

Keywords: SARS-CoV-2, COVID-19, fever, rash, Staphylococcal Scalded Skin Syndrome (SSSS), RT-PCR.

« Previous
Graphical Abstract

[1]
Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020; 91(1): 157-60.
[PMID: 32191675]
[2]
Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. Urticarial eruption in COVID‐19 infection. J Eur Acad Dermatol Venereol 2020; 34(6): e244-5.
[3]
Recalcati S. Cutaneous manifestations in COVID-19: A first perspective. J Eur Acad Dermatol Venereol 2020; 34(5): e212-3.
[http://dx.doi.org/10.1111/jdv.16387] [PMID: 32215952]
[4]
Ladhani S, Joannou CL, Lochrie DP, Evans RW, Poston SM. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin Microbiol Rev 1999; 12(2): 224-42.
[http://dx.doi.org/10.1128/CMR.12.2.224] [PMID: 10194458]
[5]
Shepardson KM, Larson K, Johns LL, et al. IFNAR2 is required for anti-influenza immunity and alters susceptibility to post-influenza bacterial superinfections. Front Immunol 2018; 9: 2589.
[http://dx.doi.org/10.3389/fimmu.2018.02589] [PMID: 30473701]
[6]
Jiehao C, Jin X, Daojiong L, et al. A Case Series of children with 2019 novel coronavirus infection: Clinical and epidemiological features. Clin Infect Dis 2020; 71(6): 1547-51.
[http://dx.doi.org/10.1093/cid/ciaa198] [PMID: 32112072]
[7]
Rahimzadeh G, Ekrami Noghabi M, Kadkhodaei Elyaderani F, et al. COVID-19 infection in Iranian children: A case series of 9 patients. J Pediatr Rev 2020; 8: 139-44.
[http://dx.doi.org/10.32598/jpr.8.2.139]
[8]
Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005; 353(24): 2559-67.
[http://dx.doi.org/10.1056/NEJMoa051721] [PMID: 16354892]
[9]
Randolph AG, Vaughn F, Sullivan R, et al. Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics 2011; 128(6): e1450-8.
[http://dx.doi.org/10.1542/peds.2011-0774] [PMID: 22065262]
[10]
Hoseininasab A, Sinaei R, Jafari M, Abbaslu P. Staphylococcus scaled skin syndrome super-infection in a covid-19 affected child: A brief case report. J Kerman Univ Med Sci 2021, In Press.
[11]
Bitar C, Chan MP, Harms PW, et al. Cutaneous manifestations of hospitalized coronavirus disease 2019 patients: A report of six cases with clinicopathologic features and viral RNA in situ hybridization. J Eur Acad Dermatol Venereol 2020; 34(11): e656-9.
[http://dx.doi.org/10.1111/jdv.16741] [PMID: 32534469]
[12]
Casas CG, Català A, Hernández CG, et al. Classification of the cutaneous manifestations of COVID-19: A rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020; 183(1): 71-7.
[http://dx.doi.org/10.1111/bjd.19163] [PMID: 32348545]
[13]
Landa N, Mendieta-Eckert M, Fonda-Pascual P, Aguirre T. Chilblain-like lesions on feet and hands during the COVID-19 pandemic. Int J Dermatol 2020; 59(6): 739-43.
[http://dx.doi.org/10.1111/ijd.14937] [PMID: 32329897]
[14]
Jones VG, Mills M, Suarez D, et al. COVID-19 and Kawasaki disease: Novel virus and novel case. Hosp Pediatr 2020; 10(6): 537-40.
[http://dx.doi.org/10.1542/hpeds.2020-0123] [PMID: 32265235]
[15]
Mazori DR, Nagarajan S, Glick SA. Recurrent reactive infectious mucocutaneous eruption (RIME): Insights from a child with three epi-sodes. Pediatr Dermatol 2020; 37(3): 545-7.
[http://dx.doi.org/10.1111/pde.14142] [PMID: 32172537]
[16]
Mohanty SK, Satapathy A, Naidu MM, et al. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) - anatomic pathology perspective on current knowledge. Diagn Pathol 2020; 15(1): 103.
[http://dx.doi.org/10.1186/s13000-020-01017-8] [PMID: 32799894]

Rights & Permissions Print Cite
Article Metrics
10
© 2024 Bentham Science Publishers | Privacy Policy